Wear it pink this October Wear pink. Raise money. Help make life-changing breast cancer research and support happen.
Book a Public Health Talk Raise awareness of breast cancer in your local community or network by booking a free online or in-person talk.
Home About us Media Breast Cancer Now media statements 210 results Breast Cancer Now responds to Cancer Research UK’s estimate that the number of people diagnosed with cancer will ‘rise by a third by 2040’ 03 Feb 2023 1 min read We respond to research about the benefits of exercise 18 Nov 2022 1 min read We respond to research about radiotherapy and long-term breast cancer survival 18 Nov 2022 1 min read We respond to research about women with benign breast disease being at higher risk of breast cancer in the long term 17 Nov 2022 1 min read We respond to latest NHSE Cancer Wait Times data 11 Nov 2022 1 min read We respond to NICE’s devastating decision to provisionally reject the use of olaparib on the NHS 10 Nov 2022 2 min read We respond to the launch of the first UK proton beam therapy trial for breast cancer patients 03 Jan 2023 1 min read We respond to new estimates that 57,215 people were living with secondary (metastatic) breast cancer in England in 2020 to 2021 22 Dec 2022 2 min read We respond to NICE’s approval of trastuzumab deruxtecan (Enhertu) for use on the Cancer Drugs Fund 20 Dec 2022 1 min read We respond to double SMC drug announcement - adjuvant abemaciclib and alpelisib with fulvestrant 12 Dec 2022 2 min read Pembrolizumab in combination with chemo is approved for use on the NHS in Scotland 10 Oct 2022 1 min read We respond to research about a potential new treatment for advanced breast cancer patients 08 Dec 2022 1 min read Previous 1 ... 10 ... 18 Next
Breast Cancer Now responds to Cancer Research UK’s estimate that the number of people diagnosed with cancer will ‘rise by a third by 2040’ 03 Feb 2023 1 min read
We respond to research about radiotherapy and long-term breast cancer survival 18 Nov 2022 1 min read
We respond to research about women with benign breast disease being at higher risk of breast cancer in the long term 17 Nov 2022 1 min read
We respond to NICE’s devastating decision to provisionally reject the use of olaparib on the NHS 10 Nov 2022 2 min read
We respond to the launch of the first UK proton beam therapy trial for breast cancer patients 03 Jan 2023 1 min read
We respond to new estimates that 57,215 people were living with secondary (metastatic) breast cancer in England in 2020 to 2021 22 Dec 2022 2 min read
We respond to NICE’s approval of trastuzumab deruxtecan (Enhertu) for use on the Cancer Drugs Fund 20 Dec 2022 1 min read
We respond to double SMC drug announcement - adjuvant abemaciclib and alpelisib with fulvestrant 12 Dec 2022 2 min read
Pembrolizumab in combination with chemo is approved for use on the NHS in Scotland 10 Oct 2022 1 min read
We respond to research about a potential new treatment for advanced breast cancer patients 08 Dec 2022 1 min read
